Company intelligence / Profile preview

Sanoptis

Germany

Ownership: Private
Employees: ~4900
Development stage: Other

Overview

Sanoptis is Europe’s second-largest ophthalmology services provider, with a network of over 460 locations and 4,900 employees, performing 3.4 million patient treatments per year including advanced surgeries and intravitreal injections. It is recognized for quality care, medical innovation, and strategic partnerships with leading eye doctors. Recent growth is supported by investments from major private equity groups and strategic tech/AI collaborations.

Therapeutic areas: Ophthalmology
Industry: Non-Academic Healthcare

Partnerships

Ikerian AG/RetinAI U.S. Inc (AI image analysis and clinical workflow automation)

Beyond the preview

Go deeper on Sanoptis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanoptis.

Explore the full profile